XML 15 R4.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Income Statement [Abstract]        
Revenues $ 452,674 $ 1,253,056 $ 1,418,219 $ 4,144,919
Costs and Expenses:        
Cost of revenues (exclusive of depreciation shown below) 1,332,153 2,291,571 4,769,059 6,445,282
Research, development and manufacturing operations (exclusive of depreciation shown below) 1,660,203 1,731,670 5,131,969 5,102,379
Selling, general and administrative (exclusive of depreciation shown below) 2,576,297 2,872,114 8,519,993 9,235,606
Depreciation and amortization 422,971 1,391,947 3,180,529 4,244,349
Total Costs and Expenses 5,991,624 8,287,302 21,601,550 25,027,616
Loss from Operations (5,538,950) (7,034,246) (20,183,331) (20,882,697)
Other Income/(Expense), net 42,789 (94,983) 75,122 (60,294)
Interest expense (1,789,599) (3,580,371) (5,442,591) (18,788,664)
Deemed interest expense on warrant liability 0 0 0 (909,092)
Change in fair value of derivatives and gain/(loss) on extinguishment of liabilities, net (4,500,151) 4,596,398 (7,928,578) 5,402,099
Total Other Income/(Expense) (6,246,961) 921,044 (13,296,047) (14,355,951)
Net Loss $ (11,785,911) $ (6,113,202) $ (33,479,378) $ (35,238,648)
Net Loss Per Share (Basic and diluted) (in dollars per share) $ (0.15) $ (2.16) $ (0.94) $ (12.75)
Weighted Average Common Shares Outstanding (Basic and diluted) (in shares) 80,896,300 2,830,503 35,806,147 2,763,991